Related Experiment Videos
1,2-Dibromoethane initiation of hepatic nodules in Sprague-Dawley rats selected with Solt-Farber system
Abstract:
Initiating effects of the fumigant 1,2-dibromoethane (DBE) for liver were examined using the Solt-Farber selection system. Male Sprague Dawley rats (230-260 g) were given one oral dose of DBE (75 mg/kg), a two-thirds partial hepatectomy 4 h later, five oral doses of 2-acetylamidofluorene (AAF) (25 mg/kg) on days 17-21, CCl4 (2 ml/kg) on day 22, a booster dose of AAF (10 mg/kg) on day 32, and were sacrificed on day 82. Nodules and appreciable gamma-glutamyl transpeptidase foci were found in the livers of four of six animals given DBE, but not in any animals of the control group.
Insights
The fumigant 1,2-dibromoethane (DBE) initiated liver damage in rats. DBE exposure led to nodules and enzyme-altered foci, indicating potential hepatocarcinogenesis.
Area of Science:
- Toxicology
- Hepatocarcinogenesis Research
- Environmental Health
Background:
- 1,2-dibromoethane (DBE) is a widely used fumigant with known toxic properties.
- Understanding the initiating effects of environmental toxins on liver health is crucial for public health.
- The Solt-Farber selection system is a validated model for studying liver cancer initiation.
Purpose of the Study:
- To investigate the potential of 1,2-dibromoethane (DBE) to initiate liver damage.
- To assess the role of DBE as an initiator in a rat model of hepatocarcinogenesis.
Main Methods:
- Male Sprague Dawley rats received a single oral dose of 1,2-dibromoethane (DBE).
- A two-thirds partial hepatectomy was performed 4 hours post-DBE administration.
- Subsequent treatments included 2-acetylamidofluorene (AAF) and carbon tetrachloride (CCl4) to promote tumor development, followed by sacrifice at 82 days.
Main Results:
- Hepatocellular nodules and gamma-glutamyl transpeptidase (GGT)-positive foci were observed in 4 out of 6 rats exposed to DBE.
- No such lesions were found in the control group, indicating a specific effect of DBE.
- DBE demonstrated initiating effects on the liver, consistent with pre-neoplastic changes.
Conclusions:
- 1,2-dibromoethane (DBE) acts as an initiator in the rat liver, promoting the development of pre-neoplastic lesions.
- These findings highlight the potential hepatocarcinogenic risk associated with DBE exposure.
- Further research is warranted to elucidate the mechanisms underlying DBE-induced liver initiation.